Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.569, 2009-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Emtricitabine/tenofovir DF reduces BMD, shows ASSERT
Reactions Weekly, Vol. 1, Iss. 1324, 2010-01 ,pp. :
Emtricitabine/Tenofovir Disoproxil Fumarate
Drugs in R&D, Vol. 5, Iss. 3, 2004-01 ,pp. :
Emtricitabine/Tenofovir Disoproxil Fumarate
By Toni M. Dando Antona J. Wagstaff
Drugs, Vol. 64, Iss. 18, 2004-01 ,pp. :
Emtricitabine/nevirapine/tenofovir: Knee osteonecrosis: case report
Reactions Weekly, Vol. 1, Iss. 1400, 2012-01 ,pp. :
Add-on emtricitabine/tenofovir against mother-child transmission
Inpharma, Vol. 1, Iss. 1625, 2008-01 ,pp. :